SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BLLN

BillionToOne, Inc. (NASDAQ:BLLN)

US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
$89.92-$0.28 (-0.31%)
 
Market cap
$4.30B
Insider Score
Health Score
Analyst consensus
Listed since
Nov 6, 2025
Market Cap$4.30B-18.3%
Revenue (ttm)$436.87M+71.9%
Net Income$49.39M+447.7%
EPS$0.91+455.9%
Shares Out47.77M
PE Ratio87.61
Forward PE93.50
Dividendn/a
Ex-Dividend Daten/a
Volume819,337
Open$88.80
Previous Close$90.20
Day's Range$88.00 - $91.43
52-Week Range$61.96 - $150.44
Beta0.34
AnalystsBuy
Price Target$124.00(+37.90%)
Earnings DateMar 3, 2027

About BLLN

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Address
1035 O’Brien Drive, Menlo Park, CA, 94025, US
Market Cap
4.30 billion
Employees
713
Industrial Classification
Medical - Diagnostics & Research

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.46M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
4 Buy0 Hold0 SellAvg target $131.00 (+45.7%)

4 firms rating BLLN in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From BLLN’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-0.31%
5 Days
-14.41%
1 Month
-14.09%
6 Months
+4.38%
1 Year
-18.25%

$BLLN stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BLLN holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BLLN's directors and management

Net Shares Purchased by Insiders−20k−10k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BLLN Estimated quarterly lobbying spending

Source: U.S. Senate LDA

BLLN Revenue by Segment

$122.98MTotal
Prenatal$104.29M84.80%
Oncology$17.05M13.87%
Clinical trial support and other services$1.64M1.33%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New BLLN patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BLLN from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in BLLN

VTIVanguard Morningstar Total Stock Market ETF$67.05M
VBVanguard Morningstar Small-Cap ETF$59.53M
VBKVanguard Morningstar Small-Cap Growth ETF$33.36M
VXFVanguard Extended Market ETF$28.57M
SCHASchwab U.S. Small-Cap ETF$10.40M
LFSCF/M Emerald Life Sciences Innovation ETF$4.84M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from BLLN’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
0
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
38

News check: Short-seller attack and share decline dominate recent coverage, though defensive response and valuation analyses provide some offset.

Recent Insider Activity

Buys
0
Sells
11
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

-36.0 since Aug 21
0255075100Aug 21 — Insider Score 36.0Aug 22 — Insider Score 36.0Aug 23 — Insider Score 36.0Aug 24 — Insider Score 36.0Aug 25 — Insider Score 36.0Aug 26 — Insider Score 36.0Aug 27 — Insider Score 36.0Aug 28 — Insider Score 36.0Aug 29 — Insider Score 36.0Aug 30 — Insider Score 36.0Aug 31 — Insider Score 36.0Sep 1 — Insider Score 0.0Sep 2 — Insider Score 0.0Sep 3 — Insider Score 0.0Sep 4 — Insider Score 0.0Sep 5 — Insider Score 0.0Sep 6 — Insider Score 0.0Sep 7 — Insider Score 0.0Sep 8 — Insider Score 0.0Sep 9 — Insider Score 0.0Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 31.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Aug 21Sep 12Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

LFSCF/M Emerald Life Sciences Innovation ETF4.63%
ADDSHedgeye Index Adds ETF3.87%
SPITF/m Emerald Special Situations ETF2.18%
XHSState Street SPDR S&P Health Care Services ETF1.82%
GNOMGlobal X - Genomics & Biotechnology ETF1.68%
PCSGPolen 5Perspectives Small-Mid Growth ETF1.48%
EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF1.05%
WSMDWasatch Small/Mid Cap ETF0.89%
IPORenaissance IPO ETF0.62%
TMEDT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF0.59%
AIMSAcuitas Small Cap Active ETF0.42%
TSEET. Rowe Price Small Cap ETF0.36%

Weight is the stock’s share of each fund’s holdings.